a manufacturer of biopharmaceutical products
Industry PharmaceuticalsOther
A.I.dvisor tells us that EBS and AMRX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EBS and AMRX's prices will move in lockstep.
Ticker / NAME | Correlation To EBS | 1D Price Change % | ||
---|---|---|---|---|
EBS | 100% | +3.15% | ||
AMRX - EBS | 29% Poorly correlated | +1.77% | ||
ZOM - EBS | 29% Poorly correlated | -0.30% | ||
ZTS - EBS | 29% Poorly correlated | +0.20% | ||
EVO - EBS | 27% Poorly correlated | +3.81% | ||
SNDL - EBS | 27% Poorly correlated | -0.48% | ||
More |